[1]
A. Joshi, A. Birla, A. Prasad, and S. Warrier, “Bioequivalence study of a fixed-dose combination of Dapagliflozin/ Vildagliptin Sustained Release tablets in healthy adult male subjects: A Randomized, Open-Label, Crossover Study”, J. Drug Delivery Ther., vol. 12, no. 6, pp. 105–109, Nov. 2022, doi: 10.22270/jddt.v12i6.5798.